2016 Q4 Form 10-Q Financial Statement

#000117184317000709 Filed on February 07, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2015 Q4
Revenue $18.27M $15.69M
YoY Change 16.42% 12.18%
Cost Of Revenue $11.06M $9.013M
YoY Change 22.68% 9.33%
Gross Profit $7.209M $6.677M
YoY Change 7.97% 16.27%
Gross Profit Margin 39.46% 42.56%
Selling, General & Admin $6.018M $4.697M
YoY Change 28.11% 13.84%
% of Gross Profit 83.48% 70.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $388.6K $348.7K
YoY Change 11.43% 51.7%
% of Gross Profit 5.39% 5.22%
Operating Expenses $6.018M $4.697M
YoY Change 28.11% 13.84%
Operating Profit $1.191M $1.980M
YoY Change -39.83% 22.47%
Interest Expense $50.00K $30.00K
YoY Change 66.67% 0.0%
% of Operating Profit 4.2% 1.52%
Other Income/Expense, Net
YoY Change
Pretax Income $1.244M $2.013M
YoY Change -38.21% 22.59%
Income Tax $367.0K $525.9K
% Of Pretax Income 29.5% 26.12%
Net Earnings $876.9K $1.487M
YoY Change -41.04% 39.1%
Net Earnings / Revenue 4.8% 9.48%
Basic Earnings Per Share $0.06 $0.11
Diluted Earnings Per Share $0.06 $0.11
COMMON SHARES
Basic Shares Outstanding 13.57M 13.29M
Diluted Shares Outstanding 13.79M 13.58M

Balance Sheet

Concept 2016 Q4 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.00M $29.40M
YoY Change 2.04% 21.99%
Cash & Equivalents $22.06M $20.70M
Short-Term Investments $7.900M $8.700M
Other Short-Term Assets $976.6K $556.1K
YoY Change 75.6% -80.14%
Inventory $8.715M $6.944M
Prepaid Expenses
Receivables $7.451M $5.020M
Other Receivables $0.00 $0.00
Total Short-Term Assets $47.13M $41.96M
YoY Change 12.31% 14.03%
LONG-TERM ASSETS
Property, Plant & Equipment $5.904M $5.552M
YoY Change 6.35% 38.79%
Goodwill $2.571M $2.571M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $13.30M $6.800M
YoY Change 95.59% -18.07%
Other Assets $439.6K $345.5K
YoY Change 27.23% 15.16%
Total Long-Term Assets $22.20M $15.23M
YoY Change 45.69% 0.23%
TOTAL ASSETS
Total Short-Term Assets $47.13M $41.96M
Total Long-Term Assets $22.20M $15.23M
Total Assets $69.33M $57.20M
YoY Change 21.2% 10.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.422M $2.183M
YoY Change 10.92% -12.67%
Accrued Expenses $120.8K $103.4K
YoY Change 16.85% -92.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.443M $3.681M
YoY Change 20.7% -5.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $200.0K
YoY Change 0.0%
Total Long-Term Liabilities $658.5K $386.5K
YoY Change 70.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.443M $3.681M
Total Long-Term Liabilities $658.5K $386.5K
Total Liabilities $5.102M $4.067M
YoY Change 25.43% 1.69%
SHAREHOLDERS EQUITY
Retained Earnings $6.009M -$3.362M
YoY Change -278.71%
Common Stock $141.5K $137.1K
YoY Change 3.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $64.22M $53.13M
YoY Change
Total Liabilities & Shareholders Equity $69.33M $57.20M
YoY Change 21.2% 10.0%

Cashflow Statement

Concept 2016 Q4 2015 Q4
OPERATING ACTIVITIES
Net Income $876.9K $1.487M
YoY Change -41.04% 39.1%
Depreciation, Depletion And Amortization $388.6K $348.7K
YoY Change 11.43% 51.7%
Cash From Operating Activities -$605.3K $1.910M
YoY Change -131.69% 77.91%
INVESTING ACTIVITIES
Capital Expenditures $529.3K $226.7K
YoY Change 133.47% -87.15%
Acquisitions
YoY Change
Other Investing Activities -$4.980M $700.0K
YoY Change -811.43% -369.23%
Cash From Investing Activities -$5.510M $475.3K
YoY Change -1259.36% -123.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$169.5K $139.2K
YoY Change -221.74% 115.68%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 159.2K 242.4K
YoY Change -34.32% -483.02%
NET CHANGE
Cash From Operating Activities -605.3K 1.910M
Cash From Investing Activities -5.510M 475.3K
Cash From Financing Activities 159.2K 242.4K
Net Change In Cash -5.956M 2.628M
YoY Change -326.67% -358.27%
FREE CASH FLOW
Cash From Operating Activities -$605.3K $1.910M
Capital Expenditures $529.3K $226.7K
Free Cash Flow -$1.135M $1.683M
YoY Change -167.4% -343.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
16291079
CY2016Q3 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
13701821
CY2016Q4 clfd Number Of Patents Granted
NumberOfPatentsGranted
9
CY2016Q4 clfd Number Of Patents Pending
NumberOfPatentsPending
9
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2421585
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2573292
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7450917
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7999210
CY2016Q3 clfd Heldtomaturity Securities Debt Maturities After One Through Three Years Net Carrying Amount
HeldtomaturitySecuritiesDebtMaturitiesAfterOneThroughThreeYearsNetCarryingAmount
10703000
CY2016Q4 clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
32984
CY2015Q4 clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
15890
CY2016Q4 clfd Heldtomaturity Securities Debt Maturities After One Through Three Years Net Carrying Amount
HeldtomaturitySecuritiesDebtMaturitiesAfterOneThroughThreeYearsNetCarryingAmount
13281000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
120803
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75306
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1900741
CY2016Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4697138
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58073263
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57320515
CY2016Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
593746
CY2015Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
226767
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
90473
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
93473
CY2016Q4 us-gaap Assets
Assets
69325513
CY2016Q3 us-gaap Assets
Assets
70595313
CY2016Q4 us-gaap Assets Current
AssetsCurrent
47130101
CY2016Q3 us-gaap Assets Current
AssetsCurrent
51112678
CY2016Q4 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt 0; font-size: 10pt"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Basis of Presentation</div></div> <div style=" margin: 0pt 0; font-size: 10pt"><div style="display: inline; font-weight: bold;">&nbsp;</div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"><div style="display: inline; color: black">The accompanying (a) condensed balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> which has been derived from audited financial statements, and (b) unaudited interim condensed financial statements have been prepared by the Company in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and Exchange Commission. Pursuant to these rules and regulations, certain financial information and footnote disclosures normally included in the financial statements have been condensed or omitted. However, in the opinion of management, the financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the financial position and results of operations and cash flows of the interim periods presented. </div>Operating results for the interim periods presented are not necessarily indicative of results to be expected for the full year or for any other interim period, due to variability in customer purchasing patterns and seasonal, operating and other factors. <div style="display: inline; color: black">These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">In preparation of the Company&#x2019;s financial statements, management is required to make estimates and assumptions that affect reported amounts of assets and liabilities and related revenues and expenses during the reporting periods. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Improvements to Employee Share-Based Payment Accounting</div>. The standard is required to be adopted by all companies in their <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> fiscal year beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> but allows companies to early adopt prior to this date. The standard is intended to simplify various aspects of the accounting and presentation of share-based payments. During the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company elected to early adopt this standard as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> Adoption of this standard impacted the previously filed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Q for the period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> as follows:</div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"><div style="display: inline; font-style: italic;">Statement of earnings </div>&#x2013; The standard requires that the tax effects of stock-based compensation be recognized in the income tax provision of the Company&#x2019;s Statements of Earnings. Previously, these amounts were recognized in additional paid-in capital on the Company&#x2019;s Balance Sheets. The new standard requires these amounts to be recasted within these quarters due to the prospective adoption of this standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Accordingly, a net tax benefit related to stock-based compensation awards of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$104,134</div> for the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> was recognized as a reduction of income tax expense in the statements of earnings. This tax benefit reduced our effective income tax rate <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5.2%</div> for the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> and resulted in an increase in basic and diluted earnings per share of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> for the quarter ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"><div style="display: inline; font-style: italic;">Statement of cash flows </div>&#x2013; The standard requires that excess tax benefits from share-based employee awards be reported as operating activities in the consolidated statements of cash flows. Previously, these cash flows were included as hypothetical inflows and outflows in both the operating and financing activities. We elected to apply this change on a prospective basis, resulting in an increase in net cash provided by operating activities and a decrease in net cash used by financing activities of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$348,000</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div>
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22057906
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28014321
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18071210
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20699033
CY2016Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5956415
CY2015Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2627823
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14145164
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14126279
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14145164
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14126279
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
141452
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
141263
CY2016Q4 us-gaap Cost Of Revenue
CostOfRevenue
11057442
CY2015Q4 us-gaap Cost Of Revenue
CostOfRevenue
9012919
CY2016Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
CY2015Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
478887
CY2016Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
246695
CY2016Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
243755
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
411779
CY2016Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
411779
CY2016Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
388625
CY2015Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
348749
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2016Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.295
CY2015Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
6860649
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P7Y292D
CY2016Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
CY2015Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1390
CY2016Q4 us-gaap Goodwill
Goodwill
2570511
CY2016Q3 us-gaap Goodwill
Goodwill
2570511
CY2016Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016Q4 us-gaap Gross Profit
GrossProfit
7208720
CY2015Q4 us-gaap Gross Profit
GrossProfit
6676796
CY2016Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
21211075
CY2016Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
16230075
CY2016Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
7930075
CY2016Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
5527075
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1243930
CY2015Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2013320
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
367000
CY2015Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
525866
CY2016Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
12250
CY2015Q4 us-gaap Income Taxes Paid
IncomeTaxesPaid
15884
CY2016Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2899667
CY2015Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1352732
CY2016Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-548293
CY2015Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-991240
CY2016Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
341490
CY2015Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-239335
CY2016Q4 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-228259
CY2015Q4 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
162927
CY2016Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2066273
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2199088
CY2016Q4 us-gaap Inventory Net
InventoryNet
8714645
CY2016Q3 us-gaap Inventory Net
InventoryNet
8373155
CY2016Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5997636
CY2016Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5702762
CY2016Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
650736
CY2016Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
471305
CY2016Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
52734
CY2015Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
33539
CY2016Q4 us-gaap Liabilities
Liabilities
5101603
CY2016Q3 us-gaap Liabilities
Liabilities
8001270
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69325513
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70595313
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4443129
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7345736
CY2016Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
658474
CY2016Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
655534
CY2016Q4 us-gaap Long Term Investments
LongTermInvestments
13281000
CY2016Q3 us-gaap Long Term Investments
LongTermInvestments
10703000
CY2016Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
159191
CY2015Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-105630
CY2016Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5510302
CY2015Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
475290
CY2016Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-605304
CY2015Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
2258163
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
876930
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
1487454
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1191196
CY2015Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1979781
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
976558
CY2016Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1198917
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
439568
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
428310
CY2016Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2015Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
257242
CY2016Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10326
CY2015Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1391
CY2016Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
7440000
CY2015Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1184000
CY2016Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
529302
CY2015Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
226710
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500
CY2016Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
169500
CY2015Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
118013
CY2016Q4 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
2459000
CY2015Q4 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
1886000
CY2016Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
17
CY2015Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
34990
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5904333
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5780814
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
6009195
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5132265
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
18266162
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
15689715
CY2016Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6017524
CY2015Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4697015
CY2016Q4 us-gaap Share Based Compensation
ShareBasedCompensation
593746
CY2015Q4 us-gaap Share Based Compensation
ShareBasedCompensation
226767
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
788892
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
54800
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44800
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.09
CY2016Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.30
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y73D
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
7930075
CY2016Q3 us-gaap Short Term Investments
ShortTermInvestments
5527075
CY2015Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8000
CY2016Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
64223910
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
62594043
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
223309
CY2015Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
286483
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13790793
CY2015Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13575162
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13567484
CY2015Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13288679

Files In Submission

Name View Source Status
0001171843-17-000709-index-headers.html Edgar Link pending
0001171843-17-000709-index.html Edgar Link pending
0001171843-17-000709.txt Edgar Link pending
0001171843-17-000709-xbrl.zip Edgar Link pending
clfd-20161231.xml Edgar Link completed
clfd-20161231.xsd Edgar Link pending
clfd-20161231_cal.xml Edgar Link unprocessable
clfd-20161231_def.xml Edgar Link unprocessable
clfd-20161231_lab.xml Edgar Link unprocessable
clfd-20161231_pre.xml Edgar Link unprocessable
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_020717p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending